Skip to main content

Peer Review reports

From: Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study

Original Submission
5 Jun 2019 Submitted Original manuscript
16 Aug 2019 Author responded Author comments - Piya Rujkijyanont
28 Jul 2019 Reviewed Reviewer Report - Katherine K. Matthay
31 Jul 2019 Reviewed Reviewer Report - Alberto Garaventa
Resubmission - Version 2
16 Aug 2019 Submitted Manuscript version 2
5 Sep 2019 Author responded Author comments - Piya Rujkijyanont
24 Aug 2019 Reviewed Reviewer Report - Katherine K. Matthay
30 Aug 2019 Reviewed Reviewer Report - Alberto Garaventa
Resubmission - Version 3
5 Sep 2019 Submitted Manuscript version 3
19 Sep 2019 Author responded Author comments - Piya Rujkijyanont
Resubmission - Version 4
19 Sep 2019 Submitted Manuscript version 4
20 Sep 2019 Author responded Author comments - Piya Rujkijyanont
Resubmission - Version 5
20 Sep 2019 Submitted Manuscript version 5
Publishing
23 Sep 2019 Editorially accepted
16 Oct 2019 Article published 10.1186/s12885-019-6186-z

You can find further information about peer review here.

Back to article page
\